China Longevity Group Company Limited (1863) announced that its production, operation, and finances remain in stable condition. The company intends to continue focusing on research and development of new materials and products.

According to the latest update, the company’s shares have been suspended from trading on the Stock Exchange since 14 February 2013. The Stock Exchange has not issued any new delisting notice to date, and previous communication indicated that it would refrain from exercising its right to delist until further notice.

The Securities and Futures Commission (SFC) remains engaged in a regulatory review related to a Show Cause Letter issued in November 2014. A Resumption Application was submitted in December 2019, and, following additional meetings in 2020 and 2021, the Commission’s Board has yet to reach a final decision. The review remains ongoing, with the Commission potentially seeking further information.

China Longevity notes that trading in its shares will remain suspended until further notice.